Home » Healthcare » Pharmaceuticals » India Gastrointestinal Products Market

India Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
India Gastrointestinal Products Market Size 2023	USD 397.95 million
India Gastrointestinal Products Market, CAGR	8.16%
India Gastrointestinal Products Market Size 2032	USD 807.03 million

Market Overview

The India Gastrointestinal Products Market is projected to grow from USD 397.95 million in 2023 to USD 807.03 million by 2032, at a compound annual growth rate (CAGR) of 8.16%.

The India Gastrointestinal Products market is driven by increasing prevalence of gastrointestinal disorders, rising healthcare awareness, and improving access to treatment options. The growing adoption of advanced diagnostic tools and therapies, along with the expanding geriatric population, further fuels market growth. Additionally, the rising demand for over-the-counter gastrointestinal products and the shift towards preventive healthcare play a significant role in market expansion. Technological advancements in drug formulations, such as the development of targeted therapies and probiotics, are expected to enhance treatment efficacy and drive innovation. The growing middle-class population and rising disposable incomes are contributing to increased healthcare spending, further propelling market demand. Furthermore, the rising trend of self-medication and digital health solutions is influencing market dynamics, leading to a more personalized and accessible approach to gastrointestinal care. With these factors combined, the market is poised for steady growth in the coming years.

The India Gastrointestinal Products market is driven by key regions such as Northern, Western, Southern, and Eastern India, each showing distinct growth patterns due to varying healthcare infrastructure, disease prevalence, and consumer awareness. Northern India, with its large urban centers like Delhi and Chandigarh, exhibits high demand for advanced diagnostic and therapeutic devices. In the Western region, Maharashtra and Gujarat lead with robust healthcare facilities and an increasing focus on gastrointestinal treatments. Southern India benefits from growing medical tourism, particularly in cities like Bengaluru and Chennai, driving demand for specialized products. Eastern India, though smaller in market share, is experiencing growth due to rising healthcare access. Key players in the market include Machida Endoscope Co, Erbe Medical India Pvt Ltd, GPC Medical Ltd, Shimadzu Corporation, Karl Storz SE & Co. KG, Stryker, and Hoya, among others. These companies play a crucial role in providing advanced gastrointestinal diagnostic and therapeutic solutions across the regions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The India Gastrointestinal Products market was valued at USD 397.95 million in 2023 and is expected to reach USD 807.03 million by 2032, growing at a CAGR of 8.16%.
The increasing prevalence of gastrointestinal disorders such as acid reflux, IBS, and gastrointestinal cancers is a key market driver.
Rising consumer awareness about gastrointestinal health and the growing adoption of preventive healthcare products are fueling demand.
The trend towards over-the-counter products and the rising popularity of probiotics and digestive enzymes are shaping market growth.
Competition is intensifying with key players like Machida Endoscope Co, Erbe Medical India Pvt Ltd, and GPC Medical Ltd offering innovative diagnostic and therapeutic solutions.
Regulatory challenges and high treatment costs are significant restraints for market growth.
Regional differences in healthcare infrastructure and disease prevalence are influencing the demand across Northern, Western, Southern, and Eastern India.

Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal disorders, including irritable bowel syndrome (IBS), acid reflux, and inflammatory bowel disease (IBD), is a significant driver for the India Gastrointestinal Products market. Factors such as changing dietary habits, increased consumption of processed foods, and high-stress lifestyles have contributed to the growing number of individuals suffering from digestive ailments. For instance, a study from the Longitudinal Aging Study in India (LASI) found that the prevalence of self-reported gastrointestinal problems was around 18%, with significant variations among regions. As these conditions become more common, the demand for effective gastrointestinal products is increasing, prompting healthcare providers to expand treatment options and improve accessibility.

Growing Healthcare Awareness and Access

The growing awareness of gastrointestinal health among the Indian population is encouraging individuals to seek early diagnosis and treatment. The government’s efforts to improve healthcare infrastructure and the increasing penetration of health insurance have further boosted accessibility to gastrointestinal treatments. For instance, the National Health Mission (NHM) aims to provide universal access to equitable, affordable, and quality healthcare services, which has significantly improved healthcare infrastructure and access. As more people recognize the importance of digestive health and its impact on overall well-being, there is a corresponding rise in demand for specialized gastrointestinal products, such as probiotics, digestive enzymes, and antacids.

Advancements in Treatment Options

Technological advancements in gastrointestinal product formulations are driving market growth. The development of targeted therapies and personalized medicine has improved the efficacy of treatments for various gastrointestinal disorders. Additionally, the introduction of innovative drug delivery systems, such as oral-controlled release and combination therapies, has made treatments more convenient and effective. These advancements are attracting patients looking for more specialized and efficient options to manage their gastrointestinal conditions.

Rising Demand for Preventive Healthcare

There is a growing trend toward preventive healthcare in India, with more individuals opting for products that help maintain gastrointestinal health. This shift is driven by an increasing focus on maintaining a balanced lifestyle and avoiding the onset of chronic diseases. As consumers become more health-conscious, they are turning to dietary supplements, probiotics, and other preventive gastrointestinal products to enhance their digestive health and reduce the risk of future complications. This trend is expected to continue driving market demand in the coming years.

Market Trends

Digital Health Solutions and Telemedicine Integration

The integration of digital health solutions and telemedicine in the gastrointestinal care landscape is another prominent trend. Telemedicine platforms are making it easier for patients to consult specialists remotely, facilitating quicker diagnoses and prescriptions for gastrointestinal disorders. For instance, Germany’s Digitalisation Strategy for Health and Care emphasizes the importance of digital health solutions in improving patient care and outcomes. Additionally, mobile apps and wearable devices are being used to monitor digestive health, track symptoms, and provide real-time health advice. This digital transformation is enhancing the accessibility of gastrointestinal care, particularly in remote areas, and is expected to play a key role in shaping the future of the market.

Shift Towards Over-the-Counter Products

A significant trend in the India Gastrointestinal Products market is the growing preference for over-the-counter (OTC) medications. Consumers are increasingly opting for easily accessible, self-medication solutions to manage mild digestive issues such as acid reflux, bloating, and constipation. The convenience and affordability of OTC gastrointestinal products, coupled with growing consumer confidence in their efficacy, are boosting their popularity. This shift is driving the expansion of the OTC product segment, especially among younger, health-conscious individuals who seek instant relief from digestive discomfort.

Rise in Probiotic and Digestive Enzyme Use

Probiotics and digestive enzymes are gaining traction in the Indian market as consumers focus more on maintaining a healthy gut. The increasing awareness of the importance of gut health and its role in overall well-being has driven demand for these products. Probiotics are particularly popular for managing conditions like IBS, constipation, and diarrhea, while digestive enzymes help with nutrient absorption and alleviate bloating. This trend is expected to continue as more people adopt preventive measures for gastrointestinal health and turn to natural supplements for long-term digestive support.

Growing Popularity of Personalized Medicine

Personalized medicine is becoming a significant trend in the Indian gastrointestinal market. With advancements in genetic testing and technology, more tailored treatments are being offered to individuals suffering from gastrointestinal disorders. Personalized therapies that cater to a person’s specific health needs, such as customized diets and targeted drug treatments, are gaining popularity. This trend is transforming the way gastrointestinal issues are managed, offering patients more precise and effective solutions, which is expected to further drive market growth.

Market Challenges Analysis

Regulatory and Compliance Challenges

One of the primary challenges facing the India Gastrointestinal Products market is navigating the complex regulatory landscape. The approval processes for new drugs and dietary supplements can be lengthy and complicated, as manufacturers must comply with stringent regulations set by the Drug Controller General of India (DCGI) and other relevant authorities. For instance, the Central Drugs Standard Control Organization (CDSCO) oversees the approval and regulation of pharmaceuticals, ensuring they meet safety and efficacy standards. Additionally, ensuring the safety and efficacy of gastrointestinal products through clinical trials can be costly and time-consuming. Delays in product approvals and the lack of standardization in regulatory practices can hinder the timely introduction of innovative products to the market, slowing overall industry growth.

Price Sensitivity and Affordability

Another significant challenge is the price sensitivity of Indian consumers. While gastrointestinal products are essential for managing health, many individuals in India are unable to afford higher-priced treatments, especially in lower-income segments. This affordability gap limits the reach of premium products and restricts market penetration. Furthermore, competition from low-cost alternatives, including unbranded and generic options, is strong, making it difficult for established brands to maintain market share. Balancing cost-effective pricing with the delivery of high-quality products remains a key challenge for companies operating in this sector.

Market Opportunities

Expanding Consumer Awareness and Preventive Healthcare

One of the key opportunities in the India Gastrointestinal Products market lies in the growing awareness about digestive health and the increasing shift towards preventive healthcare. As consumers become more informed about the importance of maintaining a healthy gut, there is a rising demand for products that support long-term gastrointestinal wellness. This trend presents an opportunity for manufacturers to introduce preventive solutions such as probiotics, digestive enzymes, and dietary supplements. With an expanding middle-class population and higher disposable incomes, consumers are increasingly willing to invest in health-promoting products. Companies can leverage this opportunity by offering a wide range of affordable, effective, and easy-to-use gastrointestinal products targeting health-conscious individuals.

Digital Health Integration and E-Commerce Expansion

The rapid growth of digital health solutions and e-commerce platforms presents significant opportunities for gastrointestinal product manufacturers in India. The increasing use of smartphones, telemedicine, and online pharmacies is transforming the healthcare landscape, allowing consumers to access treatments and advice with ease. Companies can capitalize on this trend by developing digital tools that offer personalized health recommendations, symptom tracking, and consultations with gastroenterologists. Additionally, the rise of online shopping has made it easier for consumers to purchase gastrointestinal products from the comfort of their homes. This creates a robust avenue for businesses to expand their market reach, especially in rural and remote areas where access to physical retail stores may be limited. By embracing digital platforms, companies can cater to a wider audience and foster customer loyalty through convenience and tailored healthcare solutions.

Market Segmentation Analysis:

By Devices:

The India Gastrointestinal Products market is segmented by devices, with endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices being key contributors. Endoscopy devices are widely used for diagnosing and treating various gastrointestinal conditions, including cancers and ulcers, which drives their demand in the market. Ablation devices are employed in the treatment of gastrointestinal cancers, providing non-invasive methods to destroy abnormal tissues, and are gaining popularity due to advancements in minimally invasive procedures. Motility testing devices help in diagnosing disorders related to gut motility, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD), contributing to market growth. Biopsy devices play a crucial role in detecting gastrointestinal cancers and other diseases, supporting early diagnosis and improving patient outcomes. Stenting devices, used for treating blocked or narrowed gastrointestinal passages, are also in demand due to the increasing prevalence of conditions like colorectal cancer. The growing adoption of these devices is expected to continue as healthcare infrastructure improves and medical professionals adopt advanced treatment technologies.

By Indications:

The market is also segmented by indications, including gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other gastrointestinal disorders. Gastrointestinal cancers, which include cancers of the colon, stomach, and esophagus, represent a significant market driver due to their increasing incidence and the need for advanced diagnostic and treatment options. GERD, characterized by frequent acid reflux, is another common condition driving the demand for gastrointestinal products, particularly medications and endoscopic procedures. IBS and IBD are prevalent gastrointestinal disorders in India, leading to a rising need for targeted therapies and management tools. The segment of other diseases, including celiac disease and peptic ulcers, continues to contribute to market growth as awareness of gastrointestinal health improves. As the demand for effective treatments and diagnostic tools grows across these indications, the market for gastrointestinal products in India is expected to expand, driven by both an aging population and a shift toward preventive healthcare.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Northern
Western
Southern
Eastern

Regional Analysis

Northern

Northern India, comprising states like Delhi, Punjab, Haryana, and Uttar Pradesh, is a leading market for gastrointestinal products, with a market share of 35%. This region’s strong market presence can be attributed to the high population density, rapid urbanization, and rising healthcare awareness. Cities like Delhi and Chandigarh are home to advanced healthcare facilities, which support the demand for both diagnostic and therapeutic gastrointestinal devices and treatments. The prevalence of gastrointestinal disorders such as acid reflux, irritable bowel syndrome (IBS), and gastrointestinal cancers in the urban populations is driving the adoption of modern diagnostic tools like endoscopy devices and treatments. Additionally, the increasing focus on preventive healthcare in this region further fuels demand for dietary supplements and over-the-counter (OTC) products.

Western

Western India, including states like Maharashtra, Gujarat, and Rajasthan, accounts for 30% of the India Gastrointestinal Products market. This region’s strong economic growth, coupled with its advanced healthcare infrastructure, contributes to its dominance in the market. Mumbai and Ahmedabad are key hubs for healthcare innovation, with a growing number of medical centers offering specialized gastrointestinal care. Western India also sees a high demand for advanced treatment options like ablation devices and stenting devices due to the rising incidence of gastrointestinal cancers and other chronic conditions. The region’s large middle-class population, along with increasing disposable incomes, is driving the demand for both prescription-based products and OTC solutions for gastrointestinal health.

Southern

Southern India, encompassing states like Tamil Nadu, Karnataka, Andhra Pradesh, and Kerala, holds a market share of 20%. This region is witnessing robust growth due to its rapidly expanding healthcare sector and increasing consumer awareness about gastrointestinal health. Cities like Bengaluru and Chennai are emerging as important centers for medical tourism, further boosting the demand for high-quality gastrointestinal products. Additionally, the region’s emphasis on traditional and modern healthcare integration, including the use of dietary supplements and probiotics, is driving market growth. Southern India’s aging population is another contributing factor, as elderly individuals are more prone to gastrointestinal issues like IBS and acid reflux, thus increasing the demand for therapeutic and diagnostic products.

Eastern

Eastern India, which includes states such as West Bengal, Odisha, Bihar, and Assam, represents 15% of the market. While the region lags behind in market share compared to the Northern and Western regions, it is experiencing steady growth in demand for gastrointestinal products. The rising healthcare investments in cities like Kolkata, coupled with increasing healthcare awareness, are propelling market growth. However, access to healthcare in rural areas remains a challenge, limiting the penetration of advanced gastrointestinal treatments. Despite this, the rising prevalence of gastrointestinal disorders, including inflammatory bowel disease (IBD) and gastroesophageal reflux disease (GERD), is driving the need for more accessible and affordable diagnostic and therapeutic solutions. Additionally, the increasing adoption of digital healthcare services and e-commerce platforms is expected to contribute to market expansion in this region.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Machida Endoscope Co
Erbe Medical India Pvt Ltd
GPC Medical Ltd
Shimadzu Corporation
Karl Storz SE & Co. KG
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The India Gastrointestinal Products market is highly competitive, with several prominent players leading the charge in the development of advanced diagnostic and therapeutic solutions. Key players include Machida Endoscope Co, Erbe Medical India Pvt Ltd, GPC Medical Ltd, Shimadzu Corporation, Karl Storz SE & Co. KG, Stryker, Smith & Nephew, Hoya, and others. These companies are known for their cutting-edge endoscopy devices, biopsy tools, ablation and motility testing devices, and stenting products. For instance, companies like Karl Storz SE & Co. KG have been recognized for their innovative endoscopy solutions that enhance diagnostic accuracy and patient comfort. Many market leaders focus on delivering minimally invasive and cost-effective solutions, catering to the rising demand for gastrointestinal care in the country. To maintain a competitive advantage, companies in this market focus on research and development (R&D) to enhance product offerings and improve treatment outcomes. Product innovation and technological advancements are central to meeting the needs of healthcare providers and patients. Additionally, partnerships with hospitals, clinics, and local healthcare providers are crucial for expanding market reach and improving accessibility.

Companies are also expanding their footprints in emerging markets, leveraging the growing healthcare infrastructure and increasing awareness about gastrointestinal disorders. The competition is fueled by continuous efforts to enhance customer service, provide tailored solutions, and offer competitive pricing. With the growing prevalence of gastrointestinal disorders in India, the market presents significant growth opportunities for companies that can adapt to regional healthcare needs and consumer preferences.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The market concentration of India Gastrointestinal Products is moderate, with a mix of global and local players competing to capture market share. While a few large multinational companies dominate the market, several regional players also contribute significantly, especially in terms of affordability and localized solutions. This dynamic allows for a diverse range of products, from high-end diagnostic devices to cost-effective over-the-counter gastrointestinal treatments, catering to different consumer segments across the country. The market is characterized by a strong emphasis on innovation, with players continually introducing advanced technologies such as minimally invasive endoscopic procedures and automated motility testing devices. The increasing adoption of these innovations is driving market growth, particularly in urban centers with access to state-of-the-art healthcare facilities. Moreover, regional variations in disease prevalence and healthcare infrastructure are important factors shaping product offerings and distribution strategies. In terms of competition, pricing remains a key factor, with many players offering a wide range of products to suit the needs of both middle-class and high-income consumers. The growing demand for preventive and long-term gastrointestinal health solutions further influences market strategies, prompting companies to focus on consumer education and accessibility. Overall, the market is evolving, marked by a balance of established and emerging players, fostering healthy competition and innovation.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The India Gastrointestinal Products market is expected to grow steadily, driven by increasing gastrointestinal disorders and a rising healthcare awareness.
Advancements in minimally invasive diagnostic and therapeutic technologies will continue to shape the market.
There will be a growing demand for preventive healthcare products like probiotics and digestive enzymes.
The adoption of digital health solutions, such as telemedicine and e-health platforms, will enhance the accessibility of gastrointestinal treatments.
Increased healthcare investments in both urban and rural areas will improve product availability and accessibility.
The rising prevalence of gastrointestinal cancers will drive demand for diagnostic devices like endoscopes and biopsy tools.
Companies will focus on expanding their product portfolios to include both high-end devices and affordable solutions for a wider consumer base.
The market will see significant growth in the e-commerce sector, with online platforms becoming crucial for product distribution.
With an aging population, the demand for gastrointestinal products tailored to older adults will increase.
Competitive strategies will focus on product innovation, strategic collaborations, and local manufacturing to cater to regional needs.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. India GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by India 33

5.1.1. India GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By India, 2018 – 2023 33

5.2. Export Analysis by India 34

5.2.1. India GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By India, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by India 35

6.1.1. India GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By India, 2018 – 2023 35

6.2. Supply Analysis by India 36

6.2.1. India GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By India, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by India 37

7.1.1. India GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By India, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. India GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. India Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. India GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. India GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. India GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. India GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. India GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. India GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

India Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Machida Endoscope Co 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Erbe medical india pvt ltd 78

16.3. GPC Medical Ltd 78

16.4. Shimadzu Corporation 78

16.5. Karl Storz SE & Co. KG 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. India GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for India GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for India GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. India GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By India, 2018 – 2023 32

FIG NO. 5. India GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By India, 2018 – 2023 33

FIG NO. 6. India GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By India, 2018 – 2023 34

FIG NO. 7. India GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By India, 2018 – 2023 35

FIG NO. 8. India GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By India, 2018 – 2023 36

FIG NO. 9. India GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. India GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. India GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. India GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. India GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. India GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. India GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. India GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. India GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. India GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. India GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. India GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. India GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. India GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. India GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. India GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. India GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. India GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. India GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. India GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. India GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. India GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. India GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. India GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : India GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : India GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : India GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : India GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the India Gastrointestinal Products market?

The India Gastrointestinal Products market was valued at USD 397.95 million in 2023 and is projected to reach USD 807.03 million by 2032, growing at a compound annual growth rate (CAGR) of 8.16%.

What factors are driving the growth of the India Gastrointestinal Products market?

The market growth is driven by the increasing prevalence of gastrointestinal disorders, rising healthcare awareness, advancements in treatment options, and growing adoption of preventive healthcare products. Additionally, factors like an expanding geriatric population, increasing disposable incomes, and the rise of over-the-counter (OTC) products further support market expansion.

What are the key segments within the India Gastrointestinal Products market?

Key segments include:
• Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• Indications: Gastrointestinal Cancers, GERD, IBS, IBD, and Other Diseases.
• End-Users: Hospitals, Ambulatory Surgical Centers, Clinics, and Other End Users.
• Regions: Northern, Western, Southern, and Eastern India.

What are some challenges faced by the India Gastrointestinal Products market?

Challenges include navigating regulatory complexities, ensuring product affordability for price-sensitive consumers, and competing with low-cost generic alternatives. Additionally, limited healthcare infrastructure in rural areas and the high cost of advanced treatments pose significant barriers to market penetration.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –